142 related articles for article (PubMed ID: 24713092)
41. Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?
Shibru D; Hwang J; Khanafshar E; Duh QY; Clark OH; Kebebew E
Cancer; 2008 Sep; 113(5):930-5. PubMed ID: 18661512
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic accuracy of follicular variant of papillary thyroid carcinoma in fine-needle aspirates processed by ultrafast Papanicolaou stain: histologic follow-up of 125 cases.
Yang GC; Liebeskind D; Messina AV
Cancer; 2006 Jun; 108(3):174-9. PubMed ID: 16541452
[TBL] [Abstract][Full Text] [Related]
43. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
44. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
[TBL] [Abstract][Full Text] [Related]
45. Differential expression of transforming growth factor-beta in benign vs. papillary thyroid cancer nodules; a potential diagnostic tool?
Brace MD; Wang J; Petten M; Bullock MJ; Makki F; Trites J; Taylor SM; Hart RD
J Otolaryngol Head Neck Surg; 2014 Jul; 43(1):22. PubMed ID: 25927212
[TBL] [Abstract][Full Text] [Related]
46. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
[TBL] [Abstract][Full Text] [Related]
47. Hexokinase III, cyclin A and galectin-3 are overexpressed in malignant follicular thyroid nodules.
Hooft L; van der Veldt AA; Hoekstra OS; Boers M; Molthoff CF; van Diest PJ
Clin Endocrinol (Oxf); 2008 Feb; 68(2):252-7. PubMed ID: 17868400
[TBL] [Abstract][Full Text] [Related]
48. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
49. Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.
Sugishita Y; Kammori M; Yamada O; Yamazaki K; Ito K; Fukumori T; Yoshikawa K; Yamada T
Ann Surg Oncol; 2014 Jul; 21(7):2318-25. PubMed ID: 24562933
[TBL] [Abstract][Full Text] [Related]
50. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination.
Weber F; Shen L; Aldred MA; Morrison CD; Frilling A; Saji M; Schuppert F; Broelsch CE; Ringel MD; Eng C
J Clin Endocrinol Metab; 2005 May; 90(5):2512-21. PubMed ID: 15713710
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
Chen YT; Kitabayashi N; Zhou XK; Fahey TJ; Scognamiglio T
Mod Pathol; 2008 Sep; 21(9):1139-46. PubMed ID: 18587330
[TBL] [Abstract][Full Text] [Related]
52. A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
Fassina A; Cappellesso R; Simonato F; Siri M; Ventura L; Tosato F; Busund LT; Pelizzo MR; Fassan M
Cancer Cytopathol; 2014 Apr; 122(4):274-81. PubMed ID: 24327568
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples.
Mahmoudian-Sani MR; Amrollahi-Sharifabadi M; Taheri A; Hosseini SM; Tahmasebi K; Mobini GR
Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32167927
[TBL] [Abstract][Full Text] [Related]
54. [Aspiration biopsy-nucleic acid diagnosis for widely used preparative testing].
Takano T
Rinsho Byori; 2012 Feb; 60(2):132-8. PubMed ID: 22568094
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
World J Surg; 2006 May; 30(5):767-74. PubMed ID: 16547620
[TBL] [Abstract][Full Text] [Related]
56. Molecular markers for discrimination of benign and malignant follicular thyroid tumors.
Fryknäs M; Wickenberg-Bolin U; Göransson H; Gustafsson MG; Foukakis T; Lee JJ; Landegren U; Höög A; Larsson C; Grimelius L; Wallin G; Pettersson U; Isaksson A
Tumour Biol; 2006; 27(4):211-20. PubMed ID: 16675914
[TBL] [Abstract][Full Text] [Related]
57. The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma.
Yang X; Hu Y; Shi H; Zhang C; Wang Z; Liu X; Chen H; Zhang L; Cui D
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2127-2134. PubMed ID: 29951933
[TBL] [Abstract][Full Text] [Related]
58. Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma.
Igci YZ; Arslan A; Akarsu E; Erkilic S; Igci M; Oztuzcu S; Cengiz B; Gogebakan B; Cakmak EA; Demiryurek AT
Endocr Pathol; 2011 Jun; 22(2):86-96. PubMed ID: 21509594
[TBL] [Abstract][Full Text] [Related]
59. Fine-needle aspiration of thyroid follicular neoplasm: diagnostic use of thyroid peroxidase immunocytochemistry with monoclonal antibody 47.
De Micco C; Vasko V; Garcia S; Zoro P; Denizot A; Henry JF
Surgery; 1994 Dec; 116(6):1031-5. PubMed ID: 7985083
[TBL] [Abstract][Full Text] [Related]
60. Follicular neoplasms of the thyroid: importance of clinical and cytological correlation.
Granados-García M; Cortés-Flores AO; del Carmen González-Ramírez I; Cano-Valdez AM; Flores-Hernández L; Aguilar-Ponce JL
Cir Cir; 2010; 78(6):473-8. PubMed ID: 21214982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]